Board Changes

IDS site locations

Immunodiagnostic Systems Holdings plc (“IDS” or “the Company”), a leading producer of specialist diagnostic testing kits for the clinical and research markets, gives notice of a number of proposed changes at board level which reflect the Board’s desire to ensure a stable plan of succession for the management of the business.

On October 1st 2010 Roger Duggan will step down as Chief Executive Officer, remaining on the Board as Deputy Chairman and Head of the Business Development Group. At the same time, Ian Cookson, Chief Operating Officer, will become Chief Executive Officer and IDS will look to appoint a new Operations Director to take up the role previously fulfilled by Ian.